CN109619566A - A kind of nutraceutical for alleviating asthenopia - Google Patents
A kind of nutraceutical for alleviating asthenopia Download PDFInfo
- Publication number
- CN109619566A CN109619566A CN201910058220.2A CN201910058220A CN109619566A CN 109619566 A CN109619566 A CN 109619566A CN 201910058220 A CN201910058220 A CN 201910058220A CN 109619566 A CN109619566 A CN 109619566A
- Authority
- CN
- China
- Prior art keywords
- parts
- food
- ight
- daily
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000003464 asthenopia Diseases 0.000 title abstract description 14
- 239000002417 nutraceutical Substances 0.000 title abstract description 5
- 235000021436 nutraceutical agent Nutrition 0.000 title abstract description 5
- 235000013305 food Nutrition 0.000 claims abstract description 53
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims abstract description 40
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000000463 material Substances 0.000 claims abstract description 31
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 21
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 20
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 20
- 229940026510 theanine Drugs 0.000 claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 19
- 235000016709 nutrition Nutrition 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 16
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 16
- 235000021014 blueberries Nutrition 0.000 claims abstract description 16
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 15
- 230000035764 nutrition Effects 0.000 claims abstract description 15
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims abstract description 14
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 14
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims abstract description 14
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims abstract description 14
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims abstract description 14
- 235000010930 zeaxanthin Nutrition 0.000 claims abstract description 14
- 229940043269 zeaxanthin Drugs 0.000 claims abstract description 14
- 239000001775 zeaxanthin Substances 0.000 claims abstract description 14
- 210000000582 semen Anatomy 0.000 claims abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 239000011648 beta-carotene Substances 0.000 claims abstract description 10
- 229960002747 betacarotene Drugs 0.000 claims abstract description 10
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 9
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 9
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 9
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims description 18
- 239000011812 mixed powder Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 9
- 239000011122 softwood Substances 0.000 claims description 9
- 229960005375 lutein Drugs 0.000 claims description 7
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- 239000001656 lutein Substances 0.000 claims description 6
- 235000012680 lutein Nutrition 0.000 claims description 6
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- -1 taurine compound Chemical class 0.000 claims description 5
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- 235000013336 milk Nutrition 0.000 claims description 4
- 239000008267 milk Substances 0.000 claims description 4
- 210000004080 milk Anatomy 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 4
- 235000010234 sodium benzoate Nutrition 0.000 claims description 4
- 239000004299 sodium benzoate Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 235000019441 ethanol Nutrition 0.000 claims description 3
- 229960003495 thiamine Drugs 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 229920001100 Polydextrose Polymers 0.000 claims description 2
- 239000004383 Steviol glycoside Substances 0.000 claims description 2
- 239000004376 Sucralose Substances 0.000 claims description 2
- 239000005862 Whey Substances 0.000 claims description 2
- 102000007544 Whey Proteins Human genes 0.000 claims description 2
- 108010046377 Whey Proteins Proteins 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 235000021552 granulated sugar Nutrition 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- 239000002609 medium Substances 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000001259 polydextrose Substances 0.000 claims description 2
- 235000013856 polydextrose Nutrition 0.000 claims description 2
- 229940035035 polydextrose Drugs 0.000 claims description 2
- 235000010241 potassium sorbate Nutrition 0.000 claims description 2
- 239000004302 potassium sorbate Substances 0.000 claims description 2
- 229940069338 potassium sorbate Drugs 0.000 claims description 2
- 239000001509 sodium citrate Substances 0.000 claims description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
- 235000011083 sodium citrates Nutrition 0.000 claims description 2
- 229930182488 steviol glycoside Natural products 0.000 claims description 2
- 235000019411 steviol glycoside Nutrition 0.000 claims description 2
- 150000008144 steviol glycosides Chemical class 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 4
- 229920003091 Methocel™ Polymers 0.000 claims 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 3
- 241000208340 Araliaceae Species 0.000 claims 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 2
- 229930003451 Vitamin B1 Natural products 0.000 claims 2
- 229930003268 Vitamin C Natural products 0.000 claims 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 2
- 229960003080 taurine Drugs 0.000 claims 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 2
- 235000010374 vitamin B1 Nutrition 0.000 claims 2
- 239000011691 vitamin B1 Substances 0.000 claims 2
- 235000019154 vitamin C Nutrition 0.000 claims 2
- 239000011718 vitamin C Substances 0.000 claims 2
- 235000011478 zinc gluconate Nutrition 0.000 claims 2
- 239000011670 zinc gluconate Substances 0.000 claims 2
- 229960000306 zinc gluconate Drugs 0.000 claims 2
- 239000005711 Benzoic acid Substances 0.000 claims 1
- 244000131522 Citrus pyriformis Species 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- 229920001353 Dextrin Polymers 0.000 claims 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims 1
- 240000008042 Zea mays Species 0.000 claims 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims 1
- 235000010233 benzoic acid Nutrition 0.000 claims 1
- 235000005822 corn Nutrition 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 238000005469 granulation Methods 0.000 claims 1
- 230000003179 granulation Effects 0.000 claims 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims 1
- 238000007873 sieving Methods 0.000 claims 1
- 235000015424 sodium Nutrition 0.000 claims 1
- 235000013402 health food Nutrition 0.000 abstract description 8
- 235000009508 confectionery Nutrition 0.000 abstract description 3
- 235000013361 beverage Nutrition 0.000 abstract 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 description 23
- 230000004438 eyesight Effects 0.000 description 19
- 230000000694 effects Effects 0.000 description 15
- 230000036541 health Effects 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 240000004371 Panax ginseng Species 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 244000269722 Thea sinensis Species 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 6
- 210000001525 retina Anatomy 0.000 description 6
- 235000013616 tea Nutrition 0.000 description 6
- 206010016256 fatigue Diseases 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- 206010064930 age-related macular degeneration Diseases 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 229960003638 dopamine Drugs 0.000 description 3
- 208000030533 eye disease Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000002189 macula lutea Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002858 neurotransmitter agent Substances 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 244000077233 Vaccinium uliginosum Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 240000008866 Ziziphus nummularia Species 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 210000003792 cranial nerve Anatomy 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 208000001491 myopia Diseases 0.000 description 2
- 230000004379 myopia Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 230000003860 sleep quality Effects 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- XJLSEXAGTJCILF-RXMQYKEDSA-N (R)-nipecotic acid zwitterion Chemical compound OC(=O)[C@@H]1CCCNC1 XJLSEXAGTJCILF-RXMQYKEDSA-N 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000189799 Asimina triloba Species 0.000 description 1
- 235000006264 Asimina triloba Nutrition 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 235000004237 Crocus Nutrition 0.000 description 1
- 241000596148 Crocus Species 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 102000004980 Dopamine D2 Receptors Human genes 0.000 description 1
- 108090001111 Dopamine D2 Receptors Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 241001300479 Macroptilium Species 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 102000004330 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229960002719 buserelin Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 235000005471 carotenols Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a kind of prescription nutrition foods of sight protection, this health food is by daily food and ight food composition, daily raw-food material includes lutein ester, zeaxanthin, beta carotene, blueberry powder, tealeaves theanine, ginseng, premix part composition, ight food includes lutein ester, zeaxanthin, beta carotene, blueberry powder, semen ziziphi spinosae, γ-aminobutyric acid, premix part composition, this nutraceutical by daily food and ight food at times slow down asthenopia, the nutraceutical is presented as health food, candy, beverage, solid beverage etc..
Description
Technical field
The present invention relates to field of health care food, and in particular to a kind of nutraceutical for alleviating asthenopia.
Background technique
Visual fatigue is also known as asthenopia, is eye or whole body apparatus factors and spirit based on the subjective symptoms of patient's eye
The syndrome that (psychology) factor is interweaved.The symptom of visual fatigue has dry and astringent eye, foreign body sensation, eyelid sense of heaviness, blurred vision, fear
Light stream tear, eye distending pain etc., serious person is it may also occur that katzeniammer, apathetic, absent minded, decrease of memory, appetite
The whole bodies syndromes such as depressed and neck aching pain in waist and back, teenager is it may also occur that myopia or the original myopic degree of intensification etc..
In communication society, the video display terminal (vdt)s such as computer, television set have been deep into daily life, have occurred therewith
A series of problems, such as visual fatigue, is more and more.The high incidence age of studies have shown that visual fatigue is 21-50 years old, the people of this age bracket
Group's big, work strain with eye intensity, makes eyes be chronically at adjusting Set Status, is easy to produce fatigue.Constantly prolonged between at the moment
Long, intensity increases, and often operates computer or works before fluorescent screen for a long time, it has also become visual fatigue key factor shy with strangers at present.
In addition, the disease incidence of the elderly's eye disease also increases year by year.According to investigations, age-related eye macula lutea moves back damage denaturation (AMD)
It has been more than the eye disease such as glaucoma, detachment of retina, has become the first cause of the elderly's visual impairment and blindness, in 50 years old or more people
In group, the disease disease incidence about 15.5%, wherein there is 5.1% blinding.In addition, facing the student of heavy schoolwork burden, it is accustomed to eye
The unhealthy appearance for also resulting in the visual problems such as asthenopia, visual problems have become the No.1 barrier of middle and primary schools' health at present
Hinder.Modern medicine study shows the generation of vitamin and eye illness, the quality of eyesight has very close relationship.It is excessive with eye
Person, vitamin needed for needing more eyes and minerals.Nutrient needed for reasonable supplement eyes to protection eyes, is prevented
Only eyesight injury, prevention and treatment eye illness, raising eyesight are extremely important.Although visual fatigue etc. can be alleviated there is also some currently on the market
The nutriment of visual problems, but its improvement is not comprehensive, how is unable to comprehensively solve eye problems, therefore effect is unobvious
It is that the application is dedicated to solving the problems, such as while present people that visual problems, which can preferably be alleviated, more fully improve vision health
Often stay up late, it cannot be guaranteed that sufficient sleep, the time for allowing eyes to rest it is very of short duration.
Existing vision protecting foodstuff on the market alleviates hypopsia merely by supplement neccessary composition, does not account for
Different health-care effects is needed to the different periods.Therefore a kind of vision protecting foodstuff for different periods is designed, it appears outstanding
It is important.
Summary of the invention
The purpose of the present invention is to provide a kind of prescription nutrition food of sight protection, this health care product passes through daily food
With ight food at times slow down hypopsia, in order to reach said effect, concrete scheme of the invention is as follows:
A kind of prescription nutrition food of sight protection, the prescription nutrition food of sight protection is by daily food and ight food
Composition, daily food precentagewise are made of 30%-70% raw material 30%-70% auxiliary material, and daily raw-food material is in parts by weight
Including 0.05 part -20 parts of lutein ester, 0.05 part -10 parts of zeaxanthin, 0.02 part -10 parts of beta carotene, 40 parts of blueberry powder -
94.88 parts, 0.5 part -2 parts of tealeaves theanine, 5 parts of 7-10 parts of ginseng, premix -20 parts of compositions, ight food press percentage
Than being made of 30%-70% raw material and 30%-70% auxiliary material, ight raw-food material includes lutein ester 0.05 in parts by weight
Part -20 parts, 0.05 part -10 parts of zeaxanthin, 0.02 part -10 parts of beta carotene, 40 parts -94.88 parts of blueberry powder, semen ziziphi spinosae 2
Parts -10 parts, 5 parts of 0.5 part -0.8 part of γ-aminobutyric acid, premix -20 parts of compositions, auxiliary material by milk powder, PURE WHEY,
Lecithin, medium chain triglyceride, oligofructose, oligoisomaltose, polydextrose, white granulated sugar, edible glucose, resistance paste
Essence, tealeaves theanine, γ-aminobutyric acid, lutein, citric acid, sodium citrate, microcrystalline cellulose, magnesium stearate, carboxylic propyl first
3 kinds or 3 kinds base sodium cellulosate, Sucralose, steviol glycoside, sodium benzoate, potassium sorbate, edible essence composition described above.
Preferably, daily raw-food material includes 10 parts of lutein ester, 4 parts of zeaxanthin, beta carotene 6 in parts by weight
Part, 75 parts of blueberry powder, 1 part of tealeaves theanine, 8 parts of ginseng, 8 parts of premix compositions, ight raw-food material is in parts by weight
Including 10 parts of lutein ester, 5 parts of zeaxanthin, 6 parts of beta carotene, 70 parts of blueberry powder, 8 parts of semen ziziphi spinosae, γ-aminobutyric acid
0.7 part, 15 parts of premix compositions.
Preferably, daily food precentagewise is made of 60% raw material and 40% auxiliary material, ight food precentagewise by
60% raw material and 40% auxiliary material composition.
Preferably, which is characterized in that auxiliary material includes 15 parts of milk powder, 10 parts of oligofructose, carboxylic hydroxypropyl methyl in parts by weight
8 parts of sodium cellulosate, 10 parts of sodium benzoate.
Preferably, a kind of preparation method of such as prescription nutrition food of a kind of sight protection of claim 1-4, feature
It is, comprising the following steps: (1) crush: raw material is crushed respectively;(2) mixing: by weight mixing raw material, obtains mixed
Close powder A;By mixed powder A and the total mixed powder of auxiliary material;(3) softwood processed: total mixed powder is mixed with ethyl alcohol, obtains mixing softwood;(4) it makes
Grain: softwood is sieved and is pelletized, wet granular is obtained;(5) dry: wet granular being dried, the formula nutritional food of sight protection is obtained
Product.
Zeaxanthin: (3R, 3'R)-dihydroxy-beta carotene, also known as luteole, molecular formula C40H56O2, molecule
Amount is 566.88, belongs to isoprenoid, is a kind of oxygen containing carotenoid (Xanthophyll), with lutein
(lutein) belong to isomer.The luteole being mostly present in nature is all trans isomer (AllE-iso-
mer).In human body, zeaxanthin is mainly distributed in the histoorgans such as eye, liver, pancreas, kidney, spleen, ovary, to strong
Health plays an important role, and in eyes, zeaxanthin is concentrated mainly on the macula lutea district center of retina, and human body and animal can not be certainly
Body synthesizes zeaxanthin, it is necessary to be obtained by food or replenishers.
Lutein ester: lutein ester is a kind of important carotenoid aliphatic ester, character: reddish brown tiny
Grain.Primary structure is connected by two six-membered carbon rings by the long-chain of the conjugated double bond of a son Han ten eight carbon atoms, molecular weight:
1045.71 molecular formula: an important biological function of C72H116O4, lutein are exactly to protect retina, prevent with it is ultraviolet
The damage of the close blue light of line wavelength.Senile macular degeneration (mono- relatedMacularDegenera- of Age of whole world discovery
Tion, AMD) be over-65s crowd main diseases causing blindness, after natural carotenol ester and luteole ester are shot in human body,
Under the action of body fat enzyme, it is hydrolyzed into the lutein and luteole of free state.They are deposited on human eye bottom Huang with high concentration
In spot, the absorbent of near ultraviolet blue light can be used as, by capture free radical, prevent or reduce oxidation and free radical to retina band
Come injury and exercise defencive function, the incidence of AMD can be effectively reduced.
Beta carotene, β-carrotene (C40H56) are one of carotenoid and the fat-soluble chemical combination of crocus
Object, it is also most stable of natural pigment that it, which is most generally existing in nature,.In many natural foods for example: green vegetables, sweet
Potato, carrot, spinach, pawpaw, mango etc. all have β-carrotene abundant.β-carrotene is a kind of antioxidant,
It is the maintenance indispensable nutrient of human health with detoxication, in anticancer, prevention cardiovascular disease, cataract and resists
There is significant function in oxidation, and prevents a variety of degenerative disorders caused by aging and aging in turn.Carrotene nearly ten years
The concern unprecedented by medical field, the reason is that the investigation explanation of many epidemiology: often absorbing abundant carrot in diet
The crowd of element, the chance for suffering from the diseases such as artery sclerosis, certain cancerous swellings and degeneration eye illness are all significantly lower than the less Hu trailing plants of intake
The crowd of Bu Su, many zooperies also demonstrate this viewpoint.Such as: the eyesight of eyes depends on the macula lutea on eyeground, if
Do not have enough β-carrots usually go bail for shield and support, retrograde lesion, that is, aging will occur for this position
, eyesight, which can fail, even finally occurs yctalopia.This disease is mainly in the elderly, although medical field it is thought that aging one
Kind performance, but point out that this degeneration eye illness can usually prevent by absorbing enough β-carrots simultaneously.This
Great discovery allows people to be known as new understanding to carrot, it is believed that it is not only to realize balanced nutritious necessary substance, together
When additionally aid people and prevent disease, promote longevity, promote physical fitness and quality of life.
Blueberry powder, nutritional ingredient rich in Blueberry, have prevent cranial nerve aging, protection eyesight, heart tonifying,
Anticancer, the functions such as enhances the immune of the body at softening blood vessel, and nutritional ingredient is high.Wherein, since blueberry is rich in anthocyanidin, have and live
Change retina effect, eyesight can be strengthened, prevents eyeball fatigue and gazed at.And the five of the World Food Programme's recommendation are big strong
One of Kang Shuiguo.And it is studied according to the U.S., Japan, European Section scholar, often edible blueberry product, can also significantly enhance view
Power, anti-eye strain.Clinical medicine report is also shown, and the anthocyanidin in blueberry can promote the visual purple in retina cell
Regeneration, pre- myopia prevention promote eyesight.
Tealeaves theanine, it is distinctive free amino acid that theanine is the discovery that earliest to be extracted from natural plants tealeaves,
Theanine is glutamic acid gamma-buserelin, pleasantly sweet.Theanine content in tealeaves is changed because of the kind of tea, position.Tea ammonia
Acid accounts for the 1%-2% of weight in dry tea.Theanine is similar to intracerebral active material glutamine, glutamic acid on chemical constitution,
It is the main ingredient for promoting the production of body fluid in tealeaves and moistening sweet tea.Theanine content is about 1~2% of newly picked and processed tea leaves or so, in stem tea content with
Time course is reduced.The active amino acid of theanine is L-thiamine, the amino acid being naturally occurring in green tea.Tealeaves theanine
Different with general sedative, it is a kind of relaxant that it, which is a kind of amino acid of unique free form, and mood is promoted to loosen
Simultaneously without leading to sleepy or other side effects.Pass through the effect loosened and its anti-aging function, tealeaves theanine
It can safeguard the health of cardiovascular function, theanine can be obviously promoted mesencephalic centre dopamine D_2 receptors, improve intracerebral dopamine physiology
Activity.Dopamine is a kind of central neurotransmitter for activating cranial nerve cell, the close phase of emotion state of physiological activity and people
It closes.Help to mitigate operating pressure, mitigates the symptom of fatigue.
γ-aminobutyric acid, English name: γ-aminobutyricacid (GABA) γ-aminobutyric acid, chemical name: 4-
Aminobutyric acid, alias: γ-aminobutyric acid, amino acid injection-800, nipecotic acid.Molecular formula: C4H9NO2.Molecular weight: 103.1.It is widely distributed
In in animal and plant body.All contain GABA in plant such as Macroptilium, ginseng category, the seed of Chinese herbal medicine, rhizome and tissue fluid.In animal body
Interior, GABA is almost existed only in nerve fiber, and the content in mesencephalic tissue is about 0.1-0.6mg/ grams of tissue, immunology
Studies have shown that the highest region of its concentration is black substance in brain.GABA is the important inhibition of the more deep one kind of current research
Nerve mediator, it participates in a variety of metabolic activities, has very high physiological activity.Gamma amino butyric acid is in central nervous system
Critically important inhibitory neurotransmitter, it is a kind of naturally occurring non-protein composition amino acid, has extremely important physiology
Function, it can promote the reactivity of brain, brain tonic and intelligence development, and anti-epileptic promotes sleep, and beauty moisturizing delays brain aging function, can mend
Human body inhibitory neurotransmitter is filled, there is good blood pressure reduction effect.Promote kidney Fitness improvement and protective effect.Inhibit fatty liver
And obesity, activate liver function.The micro gamma aminobutanoic acid of daily iron supplement is conducive to the alleviation of heart and brain blood pressure, and can promote people
The balance of vivo acid metabolism, adjusts immune function.
Semen ziziphi spinosae, Chinese medicine name.This product is the seed of rhamnaceae plant wild jujube.It harvests when the fruit matures in the fall, by fruit
It impregnates one night, pulp is removed in stranding, pulls out, pulverizes fruit stone with stone, takes out seed, dry.Major function are as follows: nourishing the liver, calming heart, peace
Mind, arrest sweating.Restlessness of asrhenia type and insomnia is controlled, palpitation of palpitating with fear, polydipsia, abnormal sweating.Semen ziziphi spinosae decoction is oral to big white mouse or intraperitoneal injection shows
Calm and somnolence, no matter daytime or night, normal condition or coffee, the excitatory state because caused by, semen ziziphi spinosae can show above-mentioned
Effect, calm index when small white mouse is oral are 1.95, show and act synergistically with barbiturate, semen ziziphi spinosae continuous application 6
It, can make animal sleep shoal, decreased duration, i.e. generation tolerance, but can disappear after being discontinued 1 week.Oral semen ziziphi spinosae can
Make the significant reduction of defensive type motion conditioned reflex number, interior inhibition diffusion, conditioned reflex is subsided, and inhibits cat as caused by morphine
Manic phenomenon.
Ginseng, the ginsenoside in ginseng have the function of improving brain oxygen uptake capacity antifatigue.
The utility model has the advantages that
The prescription nutrition food of sight protection of the present invention is made of daily-use health-care food and ight health food, wherein daily
All guarantee health care of the present invention to eyesight in health food and ight health food containing zeaxanthin, lutein ester, blueberry powder
Effect, is then added to tealeaves theanine and ginseng in daily-use health-care food, tealeaves theanine and ginseng play raising intracerebral
Dopamine physiological activity mitigates operating pressure, mitigates the symptom effect of fatigue, the work on daytime is improved while protecting eyesight
Efficiency guarantees the vigor on daytime, reduces tired eye, is added to γ-aminobutyric acid and semen ziziphi spinosae in ight health food, and
γ-aminobutyric acid and the calm effect calmed the nerves of semen ziziphi spinosae, improve sleep quality, and repair in sleep to eyesight, daily
The problem of health food and the cooperation of ight health food fundamentally handle the blurring of image.
Specific embodiment
Below in conjunction with specific embodiment, the present invention is further elaborated.
Daily food formula see the table below 1 in the embodiment of the present invention 1~3 and comparative example 1~2
Table 1
Ight food formula see the table below 2 in the embodiment of the present invention 1~3 and comparative example 1~2
Table 2
Raw material accounts for 50% in embodiment 1, and auxiliary material accounts for 50%, and raw material accounts for 30% in embodiment 2, and auxiliary material accounts for 70%, embodiment 3
Middle raw material accounts for 70% auxiliary material and accounts for 30%.
The preparation method of embodiment 1-3 and comparative example 1-2, comprising the following steps: (1) crush: raw material is subjected to powder respectively
It is broken;(2) mixing: by weight mixing raw material, obtains mixed powder A;By mixed powder A and the total mixed powder of auxiliary material;(3) softwood processed: will
Total mixed powder is mixed with ethyl alcohol, obtains mixing softwood;(4) it pelletizes: softwood being sieved and is pelletized, wet granular is obtained;(5) dry: by wet
Grain is dried, and obtains the prescription nutrition food of sight protection.
The difference of comparative example 3 and embodiment 3 is only that daily food does not add tealeaves theanine, and ight food does not add
Add γ-aminobutyric acid.
The difference of comparative example 4 and embodiment 3 is only that daily food does not add ginseng, and ight food does not add wild jujube
Benevolence.
Comparative example 5 is certain commercially available vision protecting foodstuff.
1, acute toxicity testing:
Experimental method: SD rat (weight 180g~220g) 20, half male and half female.It is quasi- if mono- dosage group of 15g/kg.bw
Tested material 75g really is weighed, is formulated into 200ml with distilled water, by 2ml/100g.bw oral stomach-filling twice, interval time is 4 small
When, dead animal number after two weeks and general health situation are observed after stomach-filling, and tested material acute toxicity is judged according to maximal tolerance dose.
The tested material is the health care product that embodiment 1 provides.
Experimental result
3. the acute toxicity tests of table
Gender | Size of animal | Dosage g/kg.bw | Dead animal number/only | MTD(g/kg.bw) | Conclusion |
It is male | 10 | 15 | 0 | > 15 | It is nontoxic |
It is female | 10 | 15 | 0 | > 15 | It is nontoxic |
After oral contamination, animal dead is had no in two weeks, also without apparent poisoning symptom or adverse reaction, the results are shown in Table 1.
It cuts open after the test within two weeks and kills all animals, internal organs show no obvious abnormalities variation.I.e. this inspection product are to female, male SD rat
Acute oral MTD is greater than 15g/kg.bw, belongs to non-toxic type.Its experimental result of health care product and reality that other embodiments of the invention provide
It is identical to apply example 1.
2,30 days feeding trial ablactation SD rat adaptable feds of rat were randomly divided into four groups, every group 20 by weight after 1 week
Only, half male and half female.Test sets a negative control group (distilled water) and three tested material dosage groups: 1.5g, 3.5g and 5.0g/
Kg.bw (is equivalent to 30,70 and 100 times of human body recommended intake.Preparation method: 15g, 35g and 50g sample are weighed respectively, respectively
Add distilled water to 100ml).Tested material is the health care product that embodiment 1 provides.It is primary that animal presses 1ml/100g.bw stomach-filling daily, even
It is 30 days continuous.Claim a weight of animals weekly, twice to appetite and surplus appetite, and calculates food ration.It is taken the photograph respectively by Zhou Zengchong and week
Appetite calculates all food utilizations (%), while calculating total food utilization rate (%).Put to death animal after 30 days, carry out hematology,
Serum bichemisbry and histopathology and organ coefficient measurement.Negative control group and 3 dosage group animals during 30 days feed,
Ingest, drink water, stool and urine it is normal, growth and development situation and general performance are good, do not observe that evident act changes and poisoning table
It is existing.
Human feeding trial is carried out to the health care product that 1-3 of the embodiment of the present invention and comparative example 1-4 are obtained.
Tested crowd: selecting the age by the principle of voluntariness is 18~65 years old, eyesight fatiguability person.Subject Exclusion Criteria: suffer from
Infectious, traumatic eye part disease person;With eye disease patient inside and outside cornea, crystal, vitreum, eyeground pathological changes etc.;With the heart
The diseases patient such as blood vessel, the cerebrovascular, liver, kidney, hemopoietic system;Article related with tested function is taken in a short time, is influenced to knot
The judgement person of fruit;It takes other for a long time and fails terminator in relation to therapeutic agent, health care product or using other treatment methods;It does not meet
It is included in standard, not by regulation is edible or the not congruent influence effect of data or safety judgement person.
Experimental design and grouping: 480 subjects are randomly divided into embodiment 1-3 and 8 groups of comparative example 1-5, every group of 60 people,
The factors such as age, gender, eyesight are comparable, and test result is used and compareed between itself cross-reference and group.Embodiment 1-3 and
Early 10 points of comparative example 1-4 subject are taken corresponding daily protection food, and 10 points of evening takes corresponding ight protection food, comparison
5 subject of example is early, 10 points of evening respectively takes an analysis of functional food sold.
Eyesight improving effect see the table below 4
By table 4,1-3 of the embodiment of the present invention has the effect of improving eyesight well, while using the test of embodiment 1-3
Person indicates that taking rear sleep quality improves, daily abundant as possible.The above embodiments are merely illustrative of the technical solutions of the present invention and
It is unrestricted, although being described the invention in detail referring to preferred embodiment, those skilled in the art should understand that,
It can be with modification or equivalent replacement of the technical solution of the present invention are made, without departing from the objective and model of technical solution of the present invention
It encloses, is intended to be within the scope of the claims of the invention.Technology not described in detail in the present invention, shape, construction portion
It is well-known technique.
Claims (7)
1. a kind of prescription nutrition food of sight protection, which is characterized in that the prescription nutrition food of the sight protection is by daily
Food and ight food composition, the daily food precentagewise are made of 30%-70% raw material and 30%-70% auxiliary material, institute
Stating daily raw-food material in parts by weight includes 0.05 part -20 parts of lutein ester, 0.05 part -10 parts of zeaxanthin, β-carrot
Plain 0.02 part -10 parts, 40 parts -94.88 parts of blueberry powder, 0.5 part -2 parts of tealeaves theanine, 7-10 parts of ginseng, premix 5
- 20 parts of compositions of part, the ight food precentagewise are made of 30%-70% raw material and 30%-70% auxiliary material, the ight food
Product raw material includes 0.05 part -20 parts of lutein ester, 0.05 part -10 parts of zeaxanthin, 0.02 part of beta carotene-in parts by weight
10 parts, 40 parts -94.88 parts of blueberry powder, 2 parts -10 parts of semen ziziphi spinosae, 0.5 part -0.8 part of γ-aminobutyric acid, 5 parts of premix -
20 parts of compositions.
2. auxiliary material as described in claim 1 is by milk powder, PURE WHEY, lecithin, medium chain triglyceride, oligofructose, oligomeric
Isomaltose, polydextrose, white granulated sugar, edible glucose, resistant dextrin, tealeaves theanine, γ-aminobutyric acid, lutein, lemon
Lemon acid, sodium citrate, microcrystalline cellulose, magnesium stearate, carboxylic propyl methocel sodium, Sucralose, steviol glycoside, benzoic acid
3 kinds or 3 kinds sodium, potassium sorbate, edible essence composition described above.
3. a kind of prescription nutrition food of sight protection as described in claim 1, which is characterized in that the daily raw-food material
It in parts by weight include 10 parts of lutein ester, 4 parts of zeaxanthin, 6 parts of beta carotene, 75 parts of blueberry powder, tealeaves theanine 1
Part, 8 parts of ginseng, 8 parts of premix compositions, the ight raw-food material includes 10 parts of lutein ester, corn in parts by weight
15 parts of 5 parts of yellow matter, 6 parts of beta carotene, 70 parts of blueberry powder, 8 parts of semen ziziphi spinosae, 0.7 part of γ-aminobutyric acid, premix groups
At.
4. a kind of prescription nutrition food of sight protection as described in claim 1, which is characterized in that the daily food presses hundred
Ratio is divided to be made of 60% raw material and 40% auxiliary material, the ight food precentagewise is made of 60% raw material and 40% auxiliary material.
5. a kind of prescription nutrition food of sight protection as described in claim 1, which is characterized in that the auxiliary material includes cream
Powder, oligofructose, carboxylic propyl methocel sodium, sodium benzoate, the milk powder, oligofructose, carboxylic propyl methocel sodium,
The mass ratio of sodium benzoate is 60:30:5:5.
6. a kind of prescription nutrition food of sight protection as described in claim 1, which is characterized in that the premix by
VitAVitE, vitamin C, vitamin B1, zinc gluconate and taurine compound, VitAVitE,
Vitamin C, vitamin B1, zinc gluconate and taurine quality be 1:1:1:1:1:1.
7. a kind of a kind of preparation method of the prescription nutrition food of sight protection as described in claim 1-6, which is characterized in that
The following steps are included: (1) crushes: raw material is crushed respectively;(2) mixing: by weight mixing raw material, obtains mixed powder A;
By mixed powder A and the total mixed powder of auxiliary material;(3) softwood processed: total mixed powder is mixed with ethyl alcohol, obtains mixing softwood;(4) it pelletizes: will
Softwood sieving granulation, obtains wet granular;(5) dry: wet granular being dried, the prescription nutrition food of sight protection is obtained.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910058220.2A CN109619566A (en) | 2019-01-22 | 2019-01-22 | A kind of nutraceutical for alleviating asthenopia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910058220.2A CN109619566A (en) | 2019-01-22 | 2019-01-22 | A kind of nutraceutical for alleviating asthenopia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109619566A true CN109619566A (en) | 2019-04-16 |
Family
ID=66063013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910058220.2A Pending CN109619566A (en) | 2019-01-22 | 2019-01-22 | A kind of nutraceutical for alleviating asthenopia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109619566A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110521842A (en) * | 2019-05-06 | 2019-12-03 | 高思 | Human lens and retinal photoreceptor cells nutrition eye-candy improving eyesight herbal medicine candy in white |
CN111227097A (en) * | 2020-02-27 | 2020-06-05 | 山东祥宏堂医药有限公司 | Blueberry lutein ester candy tablet and preparation method thereof |
CN111227154A (en) * | 2019-12-31 | 2020-06-05 | 许昌神飞航天生物科技有限公司 | Aerospace-grade nutritional solid beverage for regulating eyesight |
CN112655971A (en) * | 2020-12-21 | 2021-04-16 | 康洛信(广东)生物科技有限公司 | Collagen peptide composition for relieving eye dryness and fatigue and preparation method thereof |
CN115316664A (en) * | 2022-04-25 | 2022-11-11 | 山西振东五和医养堂股份有限公司 | Blueberry lutein ester with eyesight protection effect and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101731350A (en) * | 2009-12-24 | 2010-06-16 | 内蒙古蒙牛阿拉乳制品有限责任公司 | Day and night separated infant milk powder |
CN103202511A (en) * | 2013-03-20 | 2013-07-17 | 吉林敖东集团长白庄参茸有限公司 | Ginseng blueberry cassia-seed solid drink |
CN105901577A (en) * | 2016-04-15 | 2016-08-31 | 胥永贵 | Nutritional agent for reinforcing brain, protecting eye and strengthening body and preparation method and application thereof |
CN108324705A (en) * | 2018-02-12 | 2018-07-27 | 成都图径生物科技有限公司 | Composition for relieving asthenopia containing theanine, γ-aminobutyric acid and anthocyanidin |
-
2019
- 2019-01-22 CN CN201910058220.2A patent/CN109619566A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101731350A (en) * | 2009-12-24 | 2010-06-16 | 内蒙古蒙牛阿拉乳制品有限责任公司 | Day and night separated infant milk powder |
CN103202511A (en) * | 2013-03-20 | 2013-07-17 | 吉林敖东集团长白庄参茸有限公司 | Ginseng blueberry cassia-seed solid drink |
CN105901577A (en) * | 2016-04-15 | 2016-08-31 | 胥永贵 | Nutritional agent for reinforcing brain, protecting eye and strengthening body and preparation method and application thereof |
CN108324705A (en) * | 2018-02-12 | 2018-07-27 | 成都图径生物科技有限公司 | Composition for relieving asthenopia containing theanine, γ-aminobutyric acid and anthocyanidin |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110521842A (en) * | 2019-05-06 | 2019-12-03 | 高思 | Human lens and retinal photoreceptor cells nutrition eye-candy improving eyesight herbal medicine candy in white |
CN111227154A (en) * | 2019-12-31 | 2020-06-05 | 许昌神飞航天生物科技有限公司 | Aerospace-grade nutritional solid beverage for regulating eyesight |
CN111227097A (en) * | 2020-02-27 | 2020-06-05 | 山东祥宏堂医药有限公司 | Blueberry lutein ester candy tablet and preparation method thereof |
CN112655971A (en) * | 2020-12-21 | 2021-04-16 | 康洛信(广东)生物科技有限公司 | Collagen peptide composition for relieving eye dryness and fatigue and preparation method thereof |
CN115316664A (en) * | 2022-04-25 | 2022-11-11 | 山西振东五和医养堂股份有限公司 | Blueberry lutein ester with eyesight protection effect and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109619566A (en) | A kind of nutraceutical for alleviating asthenopia | |
EP2138055B2 (en) | Formula food to be beneficial for visuognosis persistence and use thereof | |
CN104739921B (en) | A kind of prescription lozenge and preparation method thereof for alleviating visual fatigue | |
JP2021008447A (en) | Health keeping product composition applicable to adult female, elderly, and sub-healthy people | |
CN108157568A (en) | A kind of Combined candy for alleviating visual fatigue and its preparation method and application | |
CN102742656B (en) | Milky tea relieving asthenopia and preparation method thereof | |
CN104839688A (en) | Eye care preparation and preparation method thereof | |
CN104474018A (en) | Health-care soft capsule for relieving asthenopia | |
CN108041609B (en) | Food composition with functions of relieving visual fatigue and preventing myopia and preparation method thereof | |
CN112715729A (en) | Blueberry lutein ester tablet candy for relieving visual fatigue and preparation method thereof | |
CN106692187A (en) | Composition for improving visuognosis persistence and protecting eye health | |
KR20140034620A (en) | Composition for preventing or treating diabetbes mellitus disease containing extract of plants | |
CN102150860B (en) | Composition for easing visual fatigue and assisting in improving memory | |
CN102090637A (en) | Collagen-containing compound nutritious powder | |
CN115444134A (en) | Blueberry lutein ester chewable tablet and preparation method thereof | |
CN104940273A (en) | Vision improvement healthcare product and preparation method thereof | |
CN109619189A (en) | A kind of black fruit Sorbus alnifloria eye protecting milk tablet of sea-buckthorn and preparation method thereof | |
KR100503208B1 (en) | Diet-food composition | |
CN108338364A (en) | Composition for relieving asthenopia containing theanine and astaxanthin | |
CN104161260A (en) | Composition used for relieving asthenopia and preparation method thereof | |
CN101856429B (en) | Medicine compound with visual fatigue relieving function and preparation method thereof | |
JP4669077B1 (en) | Autonomic nerve regulator containing asparagus pseudo-leaf as active ingredient | |
CN101850028B (en) | Composition with function of relieving visual fatigue | |
CN109123674A (en) | A kind of black fruit fructus lycii compound alleviation visual fatigue piece and its preparation process | |
CN109674050A (en) | Antifatigue food compositions and antifatigue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190416 |
|
RJ01 | Rejection of invention patent application after publication |